This is a major step for us as patients. We all know the story. The doc says sadly, "You have cirrhosis, I'm sorry we have no treatment". This is a refrain we see retold thousands of times here at the Foundation and it is the path I have personally traveled. I've written that we are on the brink of a new day when we will have options. This is the dawning of that day.Read more
Where is your liver
How does your liver affect digestion?
What are the liver's metabolic functions?
How does your liver affect blood clotting?
What other proteins does your liver make?
What are the hormonal functions of your liver?
What is your liver’s role in breaking down unwanted substances?
The liver, an amazing organ!
Some Liver Facts!
Hopefully you clicked on the picture to hear the very short quote from Shakespeare. Sometimes I can't resist a bit of drama.
Since you have an interest in liver disease, I wanted to let you know that we have reached a real milestone in the development of the foundation. We intend to help change the way liver disease, particularly NASH, is managed and to save the lives of millions who do not know today that they are at risk.Read more
In every battle there are moments which mark the end of an era. They portend the beginning of something new and a time when tiny things can sprout and grow to a vast scale. We have just completed our installation and certification of our first FibroScan system for our liver screening project. We are alive and well in Texas City and a new day is dawning.
You can now schedule a FibroScan liver screening test in Texas City
The goal of the study is to identify patients who are at risk for NAFLD or NASH but do not yet have any symptoms. The study will provide information about the incidence and demographics of liver disease in the general public.
WHO CAN TAKE THE TEST? You must be at least 18 years old, not pregnant, and do not have any implanted electronic devices.
FASTING PLEASE NOTE: You should fast for at least 3 hours before the test so plan your schedule accordingly.
FibroScan liver stiffness and fat content tests are being offered for free to patients who have a high risk of liver disease, such as NAFLD or NASH. Patients who suffer from diseases that are related to obesity or lifestyle, such as type 2 diabetes, are most at risk but liver disease can be associated with a wide variety of illnesses and still present no symptoms until the organ is badly damaged.
I recently wrote about my view that for the first time a cirrhosis patient could look forward to real medical therapies. A few folks felt that I was planting false hopes and that such miracles weren't going to happen. In light of that, I thought I might provide a broader view of the situation today.
Some of you are old enough to remember that not so long ago Hep C was unknown. We called the illness non A non B hepatitis. Today we have a cure. A miracle perhaps but also a lesson.Read more
This information is primarily for physicians but may be of value to some of our patients. As a patient, it is important to know that the interpretation of a Fibroscan score is not simple. The meaning of a test depends upon what caused the liver damage as we can see in this scoring guide.
In light of this, it is important that a qualified physician makes the interpretation of your test results. Some of the guidance available for physicians is found in these documents.
The National Fatty Liver Registry (NFLR) is in its design stage. As outlined in our Screening Project introduction, there is a great need for identifying patients at risk and with liver disease. Our goal is to build the largest database of tests for liver disease in the world. At scale and full deployment, our target is one million tests per year, capturing valuable data for epidemiological and interventional research.
The fundamental goal of the Foundation is to alert the individual patient to the risks they may have of developing liver disease as a result of lifestyle issues. The Foundation is also commited to building a research resource which will deliver lasting benefit to society at large and to the research community.
The Foundation is taking a proactive, leading sponsorship role in the development of the NFLR. We are working with leading organizations and partners to design and implement this strategic project. If you have interest in being part of the effort, contact us for more information and how you can help.